{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T23:57:53Z","timestamp":1795132673091,"version":"4.10.3"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100008349","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim Corp USA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004331","name":"Johnson and Johnson","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004331","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018529","name":"Alkermes Plc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018529","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014593","name":"Neurocrine Biosciences Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Psychiatric Research"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jpsychires.2026.06.051","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T06:40:20Z","timestamp":1782888020000},"page":"518-525","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Clozapine facilitates sustained improvement in psychotic symptoms with a subsequent cascade of effects on functioning and quality of life"],"prefix":"10.1016","volume":"201","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3220-2136","authenticated-orcid":false,"given":"Brian J.","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendan","family":"Driscoll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Scheinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krista","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arlene","family":"Cuerdo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilian","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Zeigler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yael","family":"Ben-Chaim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9678-3526","authenticated-orcid":false,"given":"Leslie G.","family":"Nucifora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7572-2679","authenticated-orcid":false,"given":"Allison S.","family":"Brandt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3024-8595","authenticated-orcid":false,"given":"Russell L.","family":"Margolis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip D.","family":"Harvey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Frederick C.","family":"Nucifora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jpsychires.2026.06.051_bib1","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1192\/bjp.169.4.483","article-title":"Neutropenia and agranulocytosis in patients receiving clozapine in the UK and Ireland","volume":"169","author":"Atkin","year":"1996","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jpsychires.2026.06.051_bib2","doi-asserted-by":"crossref","DOI":"10.1093\/oxfordhb\/9780199604456.013.0049","article-title":"Causation and Explanation in Social Science","author":"Brady","year":"2011"},{"issue":"1","key":"10.1016\/j.jpsychires.2026.06.051_bib3","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1176\/ajp.151.1.20","article-title":"Effects of clozapine on positive and negative symptoms in outpatients with schizophrenia","volume":"151","author":"Breier","year":"1994","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jpsychires.2026.06.051_bib4","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1017\/S1092852914000601","article-title":"Thinking and acting beyond the positive: the role of the cognitive and negative symptoms in schizophrenia","volume":"19","author":"Carbon","year":"2014","journal-title":"CNS Spectr."},{"issue":"5","key":"10.1016\/j.jpsychires.2026.06.051_bib5","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1093\/schbul\/sbae201","article-title":"\"Short\" Versus \"Long\" duration of untreated psychosis in people with first-episode psychosis: a systematic review and meta-analysis of baseline status and Follow-Up outcomes","volume":"51","author":"Catalan","year":"2025","journal-title":"Schizophr. Bull."},{"issue":"6","key":"10.1016\/j.jpsychires.2026.06.051_bib6","doi-asserted-by":"crossref","first-page":"764","DOI":"10.4088\/JCP.15m10278","article-title":"The economic burden of schizophrenia in the United States in 2013","volume":"77","author":"Cloutier","year":"2016","journal-title":"J. Clin. Psychiatry"},{"issue":"2","key":"10.1016\/j.jpsychires.2026.06.051_bib7","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/wps.20994","article-title":"Mortality in people with schizophrenia: a systematic review and meta-analysis of relative risk and aggravating or attenuating factors","volume":"21","author":"Correll","year":"2022","journal-title":"World Psychiatry"},{"issue":"3","key":"10.1016\/j.jpsychires.2026.06.051_bib8","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1176\/appi.ajp.2012.12050599","article-title":"Comorbidities and mortality in persons with schizophrenia: a Swedish national cohort study","volume":"170","author":"Crump","year":"2013","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jpsychires.2026.06.051_bib9","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.schres.2021.11.010","article-title":"Changes in social functioning over the course of psychotic disorders-A meta-analysis","volume":"239","author":"De Winter","year":"2022","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jpsychires.2026.06.051_bib10","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1192\/S0007125000297754","article-title":"Prolonged recovery in first-episode psychosis","volume":"172","author":"Edwards","year":"1998","journal-title":"Br. J. Psychiatr. Suppl."},{"key":"10.1016\/j.jpsychires.2026.06.051_bib11","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1159\/000528513","article-title":"The lived experiences of family members and carers of people with psychosis: a bottom-up review co-written by experts by experience and academics","volume":"56","author":"Estrade","year":"2023","journal-title":"Psychopathology"},{"issue":"11","key":"10.1016\/j.jpsychires.2026.06.051_bib12","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1176\/appi.ps.201500507","article-title":"The business case for expanded clozapine utilization","volume":"67","author":"G\u00f6ren","year":"2016","journal-title":"Psychiatr. Serv."},{"issue":"11","key":"10.1016\/j.jpsychires.2026.06.051_bib13","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1176\/appi.ajp.2011.10121723","article-title":"Validating the measurement of real-world functional outcomes: phase I results of the VALERO study","volume":"168","author":"Harvey","year":"2011","journal-title":"Am. J. Psychiatry"},{"issue":"2","key":"10.1016\/j.jpsychires.2026.06.051_bib14","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.wpsyc.2012.05.004","article-title":"Predicting the severity of everyday functional disability in people with schizophrenia: cognitive deficits, functional capacity, symptoms, and health status","volume":"11","author":"Harvey","year":"2012","journal-title":"World Psychiatry"},{"key":"10.1016\/j.jpsychires.2026.06.051_bib15","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/acps.13254","article-title":"Employment among people with schizophrenia or bipolar disorder: a population-based study using nationwide registers","volume":"143","author":"Holm","year":"2021","journal-title":"Acta Psychiatr. Scand."},{"issue":"3","key":"10.1016\/j.jpsychires.2026.06.051_bib16","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1176\/appi.ajp.2016.16050503","article-title":"Treatment-resistant schizophrenia: treatment response and resistance in psychosis (TRRIP) working group consensus guidelines on diagnosis and terminology","volume":"174","author":"Howes","year":"2017","journal-title":"Am. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.jpsychires.2026.06.051_bib17","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/wps.20822","article-title":"The clinical significance of duration of untreated psychosis: an umbrella review and random-effects meta-analysis","volume":"20","author":"Howes","year":"2021","journal-title":"World Psychiatry"},{"key":"10.1016\/j.jpsychires.2026.06.051_bib18","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.pnpbp.2015.08.010","article-title":"Treatment resistant schizophrenia is associated with the worst community functioning among severely-ill highly-disabling psychiatric conditions and is the most relevant predictor of poorer achievements in functional milestones","volume":"65","author":"Iasevoli","year":"2016","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"9","key":"10.1016\/j.jpsychires.2026.06.051_bib19","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/archpsyc.1988.01800330013001","article-title":"Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine","volume":"45","author":"Kane","year":"1988","journal-title":"Arch. Gen. Psychiatry"},{"issue":"9","key":"10.1016\/j.jpsychires.2026.06.051_bib20","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1176\/appi.ajp.2020.177901","article-title":"The American psychiatric association practice guideline for the treatment of patients with schizophrenia","volume":"177","author":"Keepers","year":"2020","journal-title":"Am. J. Psychiatry"},{"issue":"8","key":"10.1016\/j.jpsychires.2026.06.051_bib21","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1001\/jamapsychiatry.2025.1155","article-title":"FDA eliminates the clozapine REMS-what comes next?","volume":"82","author":"Kelly","year":"2025","journal-title":"JAMA Psychiatry"},{"issue":"2","key":"10.1016\/j.jpsychires.2026.06.051_bib22","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/YIC.0b013e32836508e6","article-title":"The social and economic burden of treatment-resistant schizophrenia: a systematic literature review","volume":"29","author":"Kennedy","year":"2014","journal-title":"Int. Clin. Psychopharmacol."},{"issue":"3","key":"10.1016\/j.jpsychires.2026.06.051_bib23","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.22m14587","article-title":"The protective effect of clozapine on suicide: a population mortality study of statewide autopsy records in Maryland","volume":"84","author":"Lee","year":"2023","journal-title":"J. Clin. Psychiatry"},{"issue":"9896","key":"10.1016\/j.jpsychires.2026.06.051_bib24","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(13)60733-3","article-title":"Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis","volume":"382","author":"Leucht","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jpsychires.2026.06.051_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/S2215-0366(25)00297-4","article-title":"Transdiagnostic effectiveness and safety of clozapine in individuals with psychotic, affective, and personality disorders: nationwide and meta-analytic comparisons with other antipsychotics","author":"Luykx","year":"2025","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.jpsychires.2026.06.051_bib26","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1001\/archpsyc.62.9.975","article-title":"Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: a systematic review","volume":"62","author":"Marshall","year":"2005","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jpsychires.2026.06.051_bib27","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1176\/ajp.2006.163.4.600","article-title":"Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment","volume":"163","author":"McEvoy","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jpsychires.2026.06.051_bib28","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/schbul\/18.3.515","article-title":"Treatment of the neuroleptic-nonresponsive schizophrenic patient","volume":"18","author":"Meltzer","year":"1992","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.jpsychires.2026.06.051_bib29","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1001\/archpsyc.60.1.82","article-title":"Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT)","volume":"60","author":"Meltzer","year":"2003","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jpsychires.2026.06.051_bib30","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1176\/ajp.150.11.1630","article-title":"Cost effectiveness of clozapine in neuroleptic-resistant schizophrenia","volume":"150","author":"Meltzer","year":"1993","journal-title":"Am. J. Psychiatry"},{"issue":"2","key":"10.1016\/j.jpsychires.2026.06.051_bib31","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1176\/appi.ajp.163.2.204","article-title":"Myocarditis during clozapine treatment","volume":"163","author":"Merrill","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jpsychires.2026.06.051_bib32","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/S0140-6736(96)07495-8","article-title":"Global mortality, disability, and the contributions of risk factors: global burden of disease study","volume":"349","author":"Murray","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.jpsychires.2026.06.051_bib33","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.schres.2020.11.018","article-title":"Better functional capacity and cognitive performance in clozapine responders compared to non-responders: a cross-sectional study","volume":"229","author":"Nucifora","year":"2021","journal-title":"Schizophr. Res."},{"issue":"3","key":"10.1016\/j.jpsychires.2026.06.051_bib34","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1007\/s13311-017-0552-9","article-title":"Clozapine as a model for antipsychotic development","volume":"14","author":"Nucifora","year":"2017","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.jpsychires.2026.06.051_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2018.08.016","article-title":"Treatment resistant schizophrenia: clinical, biological, and therapeutic perspectives","volume":"131","author":"Nucifora","year":"2019","journal-title":"Neurobiol. Dis."},{"issue":"3","key":"10.1016\/j.jpsychires.2026.06.051_bib36","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1001\/archpsyc.62.3.247","article-title":"The lifetime risk of suicide in schizophrenia: a reexamination","volume":"62","author":"Palmer","year":"2005","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jpsychires.2026.06.051_bib37","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1001\/archpsyc.64.1.19","article-title":"Lifetime prevalence of psychotic and bipolar I disorders in a general population","volume":"64","author":"Per\u00e4l\u00e4","year":"2007","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jpsychires.2026.06.051_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0020141","article-title":"A systematic review of the prevalence of schizophrenia","volume":"2","author":"Saha","year":"2005","journal-title":"PLoS Med."},{"issue":"1","key":"10.1016\/j.jpsychires.2026.06.051_bib39","doi-asserted-by":"crossref","DOI":"10.1093\/schizbullopen\/sgaf009","article-title":"Clozapine as a long-term therapeutic choice: longitudinal analysis of schizophrenia symptoms in a naturalistic setting","volume":"6","author":"Scheinberg","year":"2025","journal-title":"Schizophr Bull Open"},{"key":"10.1016\/j.jpsychires.2026.06.051_bib40","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.psychres.2018.06.070","article-title":"The impact of delay in clozapine initiation on treatment outcomes in patients with treatment-resistant schizophrenia: a systematic review","volume":"268","author":"Shah","year":"2018","journal-title":"Psychiatry Res."},{"issue":"Suppl. 1","key":"10.1016\/j.jpsychires.2026.06.051_bib41","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1017\/S1092852914000571","article-title":"Treatment resistance and other complicating factors in the management of schizophrenia","volume":"19","author":"Strassnig","year":"2014","journal-title":"CNS Spectr."},{"key":"10.1016\/j.jpsychires.2026.06.051_bib42","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1176\/appi.ajp.2015.15030332","article-title":"Comparative effectiveness of clozapine and standard antipsychotic treatment in adults with schizophrenia","volume":"173","author":"Stroup","year":"2016","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jpsychires.2026.06.051_bib43","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0140-6736(09)60742-X","article-title":"11-Year followup of mortality in patients with schizophrenia: a populationbased cohort study (FIN11 study)","volume":"374","author":"Tiihonen","year":"2009","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.jpsychires.2026.06.051_bib44","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1176\/appi.ps.201300085","article-title":"Outcomes of medicaid beneficiaries with schizophrenia receiving clozapine only or antipsychotic combinations","volume":"66","author":"Velligan","year":"2015","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.jpsychires.2026.06.051_bib45","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/schbul\/sby052","article-title":"Clozapine and long-term mortality risk in patients with schizophrenia: a systematic review and meta-analysis of studies lasting 1.1\u201312.5 years","volume":"45","author":"Vermeulen","year":"2019","journal-title":"Schizophr. Bull."}],"container-title":["Journal of Psychiatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395626003596?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395626003596?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:35:07Z","timestamp":1790613307000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022395626003596"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":45,"alternative-id":["S0022395626003596"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychires.2026.06.051","relation":{},"ISSN":["0022-3956"],"issn-type":[{"value":"0022-3956","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clozapine facilitates sustained improvement in psychotic symptoms with a subsequent cascade of effects on functioning and quality of life","name":"articletitle","label":"Article Title"},{"value":"Journal of Psychiatric Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpsychires.2026.06.051","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}